The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight

Source :: Plus Company Updates. November 23, 2023
Publication Year :: 2023
Abstract: LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: B-cell lymphoma is a diverse group of blood cancers that originate from abnormal B lymphocytes, a type of [...]

Subjects :: Takeda Pharmaceutical Company Ltd. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Regeneron Pharmaceuticals Inc. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
Business -- Research
Antineoplastic agents -- Forecasts and trends
Non-Hodgkin's lymphomas -- Forecasts and trends
B cells -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Antimitotic agents -- Forecasts and trends
Market trend/market analysis
General interest
News, opinion and commentary

Tools